
|Articles|April 14, 2020
Glaucoma 360: New developments in pharma (Ellie Chabi, MD; Santen, Inc)
Author(s)Alex Delaney-Gesing
Advertisement
Ellie Chabi, MD, therapeutic area head for Glaucoma & Neuroprotection, lead for Artificial Intelligence Programs within Global Biomedical Science for Santen, shares insight on the company's role in the panel discussion focusing on new developments and discoveries in the glaucoma space during the 2020 Glaucoma 360 annual meeting in San Francisco, California.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Evolving glaucoma therapy: A new era of interventional strategies
2
Throwback Series: The eye that found a cancer
3
Development of maculopathy associated with systemic medications
4
Throwback Series: When tools of the past teach new lessons
5

















































.png)


